AngioDynamics, Inc. (ANGO) Insider Trading Activity

NASDAQ$12.48+0.75 (6.39%)
Market Cap
$493.3M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
409 of 849
Rank in Industry
23 of 42

ANGO Insider Trading Activity

ANGO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$654,695
3
100

Related Transactions

Trowbridge Stephen AEVP and CFO
0
$0
2
$310,688
$-310,688
Nighan Warren JRSVP Quality and Regulatory
0
$0
1
$344,006
$-344,006

About AngioDynamics, Inc.

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and …

Insider Activity of AngioDynamics, Inc.

Over the last 12 months, insiders at AngioDynamics, Inc. have bought $0 and sold $654,695 worth of AngioDynamics, Inc. stock.

On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $369,809 and sold $289,689 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $118,100 was made by Weiss Lawrence T (SVP, Chief Legal Officer) on 2025‑10‑21.

List of Insider Buy and Sell Transactions, AngioDynamics, Inc.

2026-10-29SaleTrowbridge Stephen AEVP and CFO
23,615
0.0558%
$12.27
$289,756
-4.78%
2026-10-28SaleTrowbridge Stephen AEVP and CFO
1,720
0.0041%
$12.17
$20,932
-2.10%
2026-07-30SaleNighan Warren JRSVP Quality and Regulatory
23,370
0.0564%
$14.72
$344,006
+3.72%
2025-10-21PurchaseWeiss Lawrence TSVP, Chief Legal Officer
10,000
0.0246%
$11.81
$118,100
+2.39%
2025-10-13PurchaseTrowbridge Stephen AEVP and CFO
890
0.0022%
$11.16
$9,932
+7.64%
2025-10-09PurchaseClemmer James CPresident and CEO
10,000
0.0244%
$11.15
$111,500
+7.54%
2025-01-16SaleNighan Warren JRSVP Quality and Regulatory
4,060
0.0096%
$12.31
$49,979
-19.11%
2024-10-10PurchaseNighan Warren JRSVP Quality and Regulatory
100
0.0002%
$6.08
$608
+53.26%
2024-10-08PurchaseTrowbridge Stephen AEVP and CFO
1,700
0.0033%
$5.86
$9,962
+59.95%
2024-10-07PurchaseClemmer James CPresident and CEO
20,000
0.0399%
$6.03
$120,600
+54.10%
2024-10-07PurchaseNighan Warren JRSVP Quality and Regulatory
768
0.0015%
$6.09
$4,677
+54.10%
2024-04-08PurchaseClemmer James CPresident and CEO
10,000
0.0254%
$6.70
$67,000
+11.95%
2023-01-31SaleHelsel DaveSVP Global Operations and R&D
4,633
0.0117%
$12.95
$59,997
-34.26%
2022-10-12PurchaseTrowbridge Stephen AEVP and CFO
1,083
0.0027%
$13.82
$14,967
-23.56%
2022-10-10PurchaseClemmer James CPresident and CEO
10,000
0.0264%
$15.00
$150,000
-24.97%
2022-07-29SaleHelsel DaveSVP Global Operations and R&D
5,000
0.0126%
$22.44
$112,200
-43.39%
2022-04-28SaleHelsel DaveSVP Global Operations and R&D
3,513
0.009%
$22.44
$78,832
-37.25%
2022-04-12SaleJOHNSON WESLEYdirector
1,299
0.0034%
$23.26
$30,215
-34.97%
2022-04-11SaleJOHNSON WESLEY
7,500
0.0197%
$23.05
$172,838
-31.92%
2022-01-12PurchaseTrowbridge Stephen AEVP and CFO
2,000
0.0052%
$22.64
$45,280
-6.16%
Total: 303
*Gray background shows transactions not older than one year

Insider Historical Profitability

12.8%
Trowbridge Stephen AEVP and CFO
280461
0.6669%
$3.29M54
+32.28%
Nighan Warren JRSVP Quality and Regulatory
64745
0.154%
$759,458.8522
+53.68%
Clemmer James CPresident and CEO
882529
2.0985%
$10.35M90
+18.05%
HOBBS EAMONN PPresident & CEO
100401
0.2387%
$1.18M327
+11.44%
Weiss Lawrence TSVP, Chief Legal Officer
93597
0.2226%
$1.1M10
+2.39%
BUCCI VINCENTdirector
86696
0.2062%
$1.02M90
<0.0001%
JOHNSON WESLEYdirector
79704
0.1895%
$934,927.9223
<0.0001%
Gould Kevin Jdirector
55124
0.1311%
$646,604.5231
+8.54%
DONNELLY HOWARD Wdirector
47600
0.1132%
$558,348.0031
+17.81%
DEVIVO JOSEPHPresident and CEO
38000
0.0904%
$445,740.0040
<0.0001%
Kapusta Matthew CSVP, Business Development
27005
0.0642%
$316,768.6520
+8.01%
GOLD JEFFREYdirector
25233
0.06%
$295,983.0911
+6.67%
Meteny Dennis Sdirector
21950
0.0522%
$257,473.5020
+16.07%
Keltjens JanPresident & CEO
15000
0.0357%
$175,950.0040
+18.72%
LaPorte Stevedirector
8013
0.0191%
$93,992.4980
+1.5%
Orsatti Charles Thomasdirector
2000
0.0048%
$23,460.0010
+20%
FLAHERTY ROBERT Edirector
1200
0.0029%
$14,076.0010
+19.04%
ROSSELL ROBERT MVP - Marketing
1000
0.0024%
$11,730.0017
+116.9%
Casciaro Gregory Ddirector
500
0.0012%
$5,865.0010
+19.04%
REED JAN STERNdirector
316
0.0008%
$3,706.6810
+2.38%
*Gray background shows insiders who have made transactions during last year

ANGO Institutional Investors: Active Positions

Increased Positions93+58.86%7M+18.56%
Decreased Positions68-43.04%7M-18.98%
New Positions38New4MNew
Sold Out Positions14Sold Out5MSold Out
Total Postitions183+15.82%39M-0.42%

ANGO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Divisadero Street Capital Management, Lp$46,639.008.97%3.68M+282,695+8.33%2025-09-30
Blackrock, Inc.$44,059.008.48%3.47M-56,633-1.6%2025-09-30
Systematic Financial Management Lp$32,594.006.27%2.57M+60,600+2.41%2025-09-30
Point72 Asset Management, L.P.$32,446.006.24%2.56M+609,906+31.3%2025-09-30
Vanguard Group Inc$29,977.005.77%2.36M-125,090-5.03%2025-09-30
Millennium Management Llc$22,737.004.37%1.79M+393,682+28.13%2025-09-30
Armistice Capital, Llc$20,744.003.99%1.64M+108,185+7.08%2025-09-30
Segall Bryant & Hamill, Llc$16,732.003.22%1.32M-37,140-2.74%2025-09-30
Bastion Asset Management Inc.$16,028.003.08%1.26M+304,960+31.8%2025-09-30
Dimensional Fund Advisors Lp$14,654.002.82%1.16M-16,916-1.44%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.